Goldman Sachs reiterates Venture Global stock rating on earnings preview

Goldman Sachs reiterated its Buy rating and $18 price target for Venture Global, implying roughly 35% upside from $13.29, but cut its Q3 2026 EBITDA estimate 17% to $2.517 billion, below the $2.608 billion consensus, citing softer margins and volumes. Its FY2026 EBITDA forecast is $9.03 billion, near consensus and at the top end of guidance; Goldman said the $170 million Galp arbitration damages cap appears manageable despite $42.84 billion in total debt. The article also cites prior Q2 results that beat estimates and a raised outlook, alongside investor concerns about LNG price volatility.

Analysis

The key signal is the divergence between a sharply lower quarterly EBITDA estimate and essentially unchanged full-year expectations: if accurate, the downgrade is more consistent with timing, ramp shape and basis effects than a broad reset to annual cash generation. That supports a less-bearish read-through than the headline quarterly cut, but it is not independently confirmed until reported results and realized fees are available. The counterweight is equity convexity to execution: substantial leverage makes delays, weaker realized pricing or sustained volume shortfalls more consequential for VG equity than the stated arbitration cap alone suggests. The Galp outcome is manageable in dollar terms per the cited analyst, but investors should monitor whether its contract interpretation affects other disputes or counterparties’ willingness to accept similar terms; one decision does not establish a broader pattern.

Over days, expect trading to be driven by reported results and any reconciliation of pre-sales, pricing ramp and basis against the estimate cut. Over 1–3 months, Plaquemines Phase 1’s commercial-operation timing and realized liquefaction fees are the clearest execution tests. Over 6–18 months, sustained project delivery and contracted economics matter more than analyst targets; slippage would raise the importance of balance-sheet and funding risk. Contrarian point: unchanged annual estimates argue against extrapolating one quarter’s cut, but the bullish case is not validated by a Buy rating or contract announcements. Falsify the constructive view if full-year guidance is reduced, operating milestones slip, or realized fees/volumes indicate persistent rather than timing-related weakness.

Key Decisions for Investors

• Avoid chasing VG on analyst price targets. Reassess after results provide a bridge from quarterly weakness to full-year EBITDA, including volume, realized fees, pricing ramp and basis.
• Treat VG as a high-execution-risk exposure: keep position sizing conservative until Plaquemines Phase 1 reaches commercial operation and reported operating data confirm the ramp.
• Set an alert for any full-year guidance reduction, milestone delay, or evidence that the Galp ruling affects additional contract disputes; these would invalidate the timing-only interpretation and warrant a bearish reassessment.
• No immediate trade in COP or Galp is supported by the information provided: the contract addition and single arbitration outcome do not establish material earnings effects for either company.